Both AR and TMPRSS2 are implicated in prostate cancer, and some data suggests that there may be an association between prostate cancer and depression and anxiety (Newby et al., 2015; Rice et al., 2018; Wang et al., 2020). Here, TMPRSS2 is linked to depressive symptom measurement.